Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher
February 20, 2015 at 11:14 AM EST
Shares of Novo Nordisk A/S (NYSE: NVO) were trading higher by more than 4 percent Friday morning after the company announced positive ...
